Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT Stock Healthcare Biotechnology
$2.76
+0.26 (+10.40%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+27.8%
3 Months
-55.5%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Apr 2026
-97.9%

Own LABT?

See how LABT contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.